Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-12-03
DOI
10.1038/s41467-022-35130-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anticancer activity of lactic acid bacteria
- (2022) Katarzyna Garbacz SEMINARS IN CANCER BIOLOGY
- Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity
- (2022) Yash Agarwal et al. Nature Biomedical Engineering
- Stimuli-Responsive Microneedles as a Transdermal Drug Delivery System: A Demand-Supply Strategy
- (2022) B.H. Jaswanth Gowda et al. BIOMACROMOLECULES
- Intratumoural administration and tumour tissue targeting of cancer immunotherapies
- (2021) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Bacterial Peptidoglycan Fragments Differentially Regulate Innate Immune Signaling
- (2021) Klare L. Bersch et al. ACS Central Science
- Tumor eradicated by combination of imiquimod and OX40 agonist for in situ vaccination
- (2021) Yanhong Chu et al. CANCER SCIENCE
- Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+ CD8+ T cells in tumor-draining lymph nodes
- (2021) Jason M. Schenkel et al. IMMUNITY
- Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines
- (2021) Long Chen et al. Science Translational Medicine
- Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
- (2020) Candice R. Gurbatri et al. Science Translational Medicine
- Targeting Melanoma Hypoxia with the Food-Grade Lactic Acid Bacterium Lactococcus Lactis
- (2020) Rodolfo Garza-Morales et al. Cancers
- A Combination of Cowpea Mosaic Virus and Immune Checkpoint Therapy Synergistically Improves Therapeutic Efficacy in Three Tumor Models
- (2020) Chao Wang et al. ADVANCED FUNCTIONAL MATERIALS
- Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
- (2020) Junyun Lai et al. NATURE IMMUNOLOGY
- Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
- (2020) Lukas F. Mager et al. SCIENCE
- Immunomodulatory Activity of Lactococcus lactis GCWB1176 in Cyclophosphamide-Induced Immunosuppression Model
- (2020) Sun Woo Jin et al. Microorganisms
- A Critical Role of CD40 and CD70 Signaling in Conventional Type 1 Dendritic Cells in Expansion and Antitumor Efficacy of Adoptively Transferred Tumor-Specific T Cells
- (2020) Takaaki Oba et al. JOURNAL OF IMMUNOLOGY
- Localized Interleukin-12 for Cancer Immunotherapy
- (2020) Khue G. Nguyen et al. Frontiers in Immunology
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Immune agonist antibodies face critical test
- (2019) Ken Garber NATURE REVIEWS DRUG DISCOVERY
- NK Cells Stimulate Recruitment of cDC1 into the Tumor Microenvironment Promoting Cancer Immune Control
- (2018) Jan P. Böttcher et al. CELL
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases
- (2018) Chun Gwon Park et al. Science Translational Medicine
- Eradication of spontaneous malignancy by local immunotherapy
- (2018) Idit Sagiv-Barfi et al. Science Translational Medicine
- Lactic Acid Bacteria for Delivery of Endogenous or Engineered Therapeutic Molecules
- (2018) Peter A. Bron et al. Frontiers in Microbiology
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Dendritic cell-based immunotherapy
- (2016) Rachel L Sabado et al. CELL RESEARCH
- Rationale for anti-OX40 cancer immunotherapy
- (2016) Sandrine Aspeslagh et al. EUROPEAN JOURNAL OF CANCER
- Phagocytosis: An Immunobiologic Process
- (2016) Siamon Gordon IMMUNITY
- Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
- (2016) Latha B. Pathangey et al. Oncotarget
- Oncolytic Viruses: Therapeutics With an Identity Crisis
- (2016) Caroline J. Breitbach et al. EBioMedicine
- Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer
- (2015) Sima Rahimian et al. BIOMATERIALS
- Can Pulp Fibroblasts Kill Cariogenic Bacteria? Role of Complement Activation
- (2015) C. Jeanneau et al. JOURNAL OF DENTAL RESEARCH
- Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
- (2015) Stefani Spranger et al. NATURE
- Enzyme-Degradable Self-Assembled Nanostructures from Polymer–Peptide Hybrids
- (2014) Daniel Bacinello et al. BIOMACROMOLECULES
- OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy
- (2014) Yannick Bulliard et al. IMMUNOLOGY AND CELL BIOLOGY
- Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma
- (2014) Kui Shin Voo et al. INTERNATIONAL JOURNAL OF CANCER
- Distinct localization of the complement C5b-9 complex on Gram-positive bacteria
- (2013) Evelien T. M. Berends et al. CELLULAR MICROBIOLOGY
- Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
- (2013) Melissa G. Lechner et al. JOURNAL OF IMMUNOTHERAPY
- Lactococcus lactis subsp. cremoris FC triggers IFN-γ production from NK and T cells via IL-12 and IL-18
- (2012) Akemi Kosaka et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease
- (2010) Stewart Leung et al. Cellular & Molecular Immunology
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started